For more than two decades our research focuses on the biological function, differentiation and development of the human placenta. Despite the fact that failures in implantation and early placental development result in pre-term abortions and pregnancy diseases such as preeclampsia or intra-uterine growth retardation of the fetus, little is known about the molecular mechanisms controlling placental differentiation under physiological and pathological conditions. Throughout the years our team predominantly investigated basic molecular mechanisms controlling regulation of placental hormones, placenta-specific transcription factors as well as signaling cascades controlling trophoblast invasion. Our research on these subjects resulted in the identification of novel mechanisms and genes involved in trophoblast differentiation such as factors of the Notch, Wnt-and Hippo signaling cascades.
Recently, we developed self-organizing and self-renewing human placenta-organoid systems. These placenta organoids reflect the cellular heterogeneity within the placenta, through the spontaneous formation of syncytiotrophoblastic layers and the controlled formation of invasive, extravillous trophoblasts. The advantage over conventional 2D cell culture systems lies in the preservation of the structural integrity and thus the spatial orientation of the cells to one another opening up new fields of investigations.
Due to our continuous efforts and development of our group Martin Knöfler became editor of the top journal “Placenta” and Chairman of the Award Committee of the International Federation of Placental Associations (IFPA). He is also amongst the TOP 50 most-cited Reproductive Biologists of all German-speaking scientists.
The establishment of maternal tolerance to the semi-allogeneic fetus in early pregnancy is an immunological enigma. A characteristic of this phenomenon is the controlled influx of different immune cell types into the decidua, in which maternal and fetal cells come into contact. To shed light on this topic Jürgen Pollheimer has set his focus on immunological processes and cellular interactions taking place at the fetal maternal interface such as the characterization of tissue resident uterine macrophages or the impact of high endothelial venules in the human decidua.
Jürgen Pollheimer is Editorial Board Member of the top journal “Placenta” since 2018 and became Associate Editor of the journal “Molecular Human Reproduction” in 2021.
Scopus: Sum of times cited: 2.846, h-index: 30
ORCID ID: 0000-0001-8440-5221
SCOPUS Author ID: 6507825565
Seit mehr als 20 Jahren untersuchen wir biologische Funktionen, Differenzierung und Entwicklung der humanen Plazenta. Trotz der Tatsache, dass Fehler bei Implantation und früher Plazentaentwicklung zu vorzeitigem Abort oder Schwangerschaftserkrankungen wie Präeklampsie oder intrauteriner Wachstumsretardierung des Föten führen können, sind die molekularen Mechanismen der Plazentadifferenzierung unter physiologischen und pathologischen Bedingungen größtenteils unbekannt.
Über die Jahre studierte unser Team vorwiegend die Grundlagen der Plazentaentwicklung, wie transkriptionelle Kontrolle der Schwangerschaftshormone, Plazenta-spezifische Transkriptionsfaktoren sowie Signalwege, die die Invasion des Trophoblasten kontrollieren. Unsere Forschung führte zur Identifikation neuer Kontrollmechanismen, die an der trophoblastären Entwicklung und Differenzierung beteiligt sind wie z. B. Faktoren der Notch-, Wnt- und Hippo-Signalkaskaden.
Vor kurzem etablierten wir ein sich selbst organisierendes und erneuerndes humanes Plazenta-Organoid-System. Diese Plazenta-Organoide spiegeln die zelluläre Heterogenität innerhalb der Plazenta durch die spontane Bildung von synzytiotrophoblastären Zellschichten und die kontrollierte Bildung von invasiven, extravillösen Trophoblasten, wider. Der Vorteil gegenüber 2D-Zellkultursystemen liegt in der Erhaltung der strukturellen Integrität und damit der räumlichen Ausrichtung der Zellen zueinander, wodurch neue Forschungsfelder eröffnet werden.
Aufgrund unserer kontinuierlichen Bemühungen und Weiterentwicklung unserer Gruppe wurde Martin Knöfler Editor des Top-Journals Placenta und Vorsitzender des Award Committee der International Federation of Placental Associations (IFPA). Außerdem gehört er zu den TOP 50 der meistzitierten reproduktiven Biologen aller deutschsprachigen Wissenschaftler.
Die Etablierung der mütterlichen Toleranz gegenüber dem semiallogenen Feten in der Frühschwangerschaft stellt ein immunologisches Enigma dar. Ein Charakteristikum dieses Phänomens ist der kontrollierte Influx verschiedener Immunzelltypen in die Dezidua, in der mütterliche und fetale Zellen miteinander in Kontakt treten.
Um dieses Thema näher zu beleuchten, setzte Jürgen Pollheimer seinen Fokus auf immunologische Prozesse und zelluläre Interaktionen, die an der feto-maternalen Schnittstelle stattfinden. Zu seinen Forschungsthemen zählen die Charakterisierung von gewebsansässigen uterinen Macrophagen oder der Einfluss von hochendothelialen Venolen in der menschlichen Dezidua.
Seit 2018 ist Jürgen Pollheimer Mitglied des „Editorial Board“ des Top-Journals Placenta und wurde 2021 assoziierter Editor des Journals Molecular Human Reproduction.
Scopus: Sum of times cited: 2.846, h-index: 30
ORCID ID: 0000-0001-8440-5221
SCOPUS Author ID: 6507825565
Within the placenta cytotrophoblasts of the placental villus undergo two different routes of differentiation (Figure 1). In floating villi embedded in maternal blood cytotrophoblasts fuse to form the multinucleated syncytium representing the barrier between fetal and maternal blood circulation. The syncytium also produces hormones such as placental lactogen and chorionic gonadotrophin which are essential for successful progression of pregnancy. Regulation of the latter has been intensively studied in our laboratory. We showed that cAMP-dependent factors as well as transcriptional activators of the AP-2 family are required for the differentiation-dependent expression of the two subunits of chorionic gonadotrophin, alpha and beta (Knöfler et al., 2000; Knöfler et al., 2004). Cytokines associated with pre-term labour and infection such as Tumor necrosis factor alpha (TNF-alpha) suppress chorionic gonadotrophin production and cell fusion (Leisser et al., 2006) suggesting that failed trophoblast differentiation could be associated with pregnancy diseases.
The second differentiation pathway of trophoblasts, invasive differentiation, represents another developmental process of the human placenta which is absolutely required for successful pregnancy outcome (Figure 1). In anchoring villi attaching to the uterine epithelium proliferative cell columns are formed giving rise to invasive extravillous trophoblasts. These cells invade the maternal uterine stroma as well as spiral arteries resulting in transformation of these uterine vessels. Apoptosis of smooth muscle cells as well as enlargement of vessel diameter finally ensure the appropriate blood flow to the growing placenta and fetus. Failures in this particular differentiation process were shown to be associated with gestational diseases such as preeclampsia and severe forms of fetal intra-uterine growth restriction. Details on the pathogenesis of the diseases, however, remain largely unknow
Fig. 1. Invasion of the placental trophoblast. Upon attachment of the placental anchoring villus (AV) to the uterine basement membrane, cyto-trophoblasts cells (CT) break through the multinuclear synzytium (S) which represents the transport unit of the floating villus (FV), and generate the proliferative cell column (CC). Upon growth arrest at the distal part of the CC the extravillous trophoblasts (EVT) are formed which invade into the underlying maternal decidua (D) and spiral arteries (SA) resulting in displacement of endothelial cells (EC) and establishment of blood flow into the intervillous space (IS). In deeper parts of the invasion zone (IZ) EVT form giant cells (GC) which represents another final stage of the differentiation process.
Throughout the years different trophoblast model systems including first trimester villous explant cultures, isolated primary trophoblasts and cell lines were established to investigate regulatory mechanisms controlling trophoblast invasion. Besides abundant growth factors expressed at the fetal-maternal interface trophoblast-derived chorionic gonadotrophin was found to regulate trophoblast migration and invasion (Saleh et al., 2007; Prast et al., 2008). The hormone was shown to stimulate matrix metalloproteinase 2 (MMP-2) expression through activation of ERK and AKT signalling. Another important signal transduction pathway involved in trophoblast invasion is the Wingless (Wnt) cascade. Human placenta and trophoblast express a variety of Wnt ligands and their receptors, members of the frizzled (fzd) family (Sondergger et al., 2007). Activation of Wnt signalling promoted trophoblast invasion and migration through the canonical pathway (Pollheimer et al., 2006). Recent collaborative approaches resulted in the identification of genes specifically expressed in villous or invasive, extravillous trophoblasts. One of those genes, heme oxygenase 1 was identified as a negative regulator of trophoblast motility (Bilban et al., 2008). Overexpression of the enzyme potentially suppresses trophoblast migration by increasing the transcription factor Peroxisome proliferator-activated receptor (PPAR) gamma which is known to inhibit trophoblast migration. Along those lines, we have also studied proteins such as TNF-alpha and endostatin which were shown to be increased in the serum of preeclamptic women (Hirtenlehner et al., 2003). TNF-alpha was shown to block trophoblast invasion and migration by increasing the protease inhibitor PAI-1 in different model systems (Bauer et al., 2004; Huber et al., 2006). This suggests that elevated pro-inflammatory cytokine expression at the fetal-maternal interface may contribute to the pathogenesis of preeclampsia by inhibiting invasive trophoblast differentiation. Similarly, endostatin which is also present in maternal decidua negatively affected in vitro trophoblast motility (Pollheimer et al., 2004; Pollheimer et al., 2005a).
Our findings with respect to transcription, trophoblast differentiation and signalling were summarised and combined with others data in several reviews (Knöfler et al., 2001; Loregger et al., 2003; Pollheimer et al., 2005b).
Novel routes of our laboratory involve functional studies of genes identified by differential gene expression profiling of non-invasive and invasive trophoblasts which potentially play a role in controlling trophoblast motility. Besides that, model systems of endometrial decidualisation and hormone-dependent lymphangiogenesis are currently being established in the laboratory.
Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knöfler M. (2004)
Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab, 89:812-822
Hirtenlehner, K, Pollheimer, J, Lichtenberger, C, Wolschek, MF, Zeisler, H, Husslein, P, Knöfler, M. (2003)
Elevated serum concentrations of the angiogenesis inhibitor endostatin in preeclamptic women. J Soc Gynecol Investig. 10:412-417
Huber AV, Saleh L, Bauer S, Husslein P, Knöfler M (2006)
TNF?-mediated Induction of PAI-1 Restricts Invasion of HTR-8/SVneo Trophoblast Cells. Placenta 27:127-136.
Knöfler, M., Saleh, L., Bauer, S., Vasicek, R., Griesinger, G., Strohmer, H., Helmer, H. and Husslein, P. (2000)
Promoter-Elements and Transcription Factors involved in Differentiation-dependent Human Chorionic Gonadotrophin-? mRNA Expression of Term Villous Trophoblasts. Endocrinology, 141: 3737-48
Knöfler M, Vasicek R, Schreiber M. (2001)
Key Regulatory Transcription Factors Involved in Placental Trophoblast Development-A Review. Placenta, 22:83-92
Knöfler M, Saleh L, Bauer S, Galos B, Rotheneder H, Husslein P, Helmer H. (2004)
Transcriptional Regulation of the Human Chorionic Gonadotrophin {beta} Gene during Villous Trophoblast Differentiation. Endocrinology, 145:1685-1694.
Leisser C, Saleh L, Haider S, Husslein H, Sonderegger S, Knöfler M. (2006)
Tumour necrosis factor-alpha impairs chorionic gonadotrophin beta-subunit expression and cell fusion of human villous cytotrophoblast. Mol Hum Reprod. 12:601-9.
Loregger, T., Pollheimer, J., and Knöfler, M. (2003)
Regulatory transcription factors controlling function and differentiation of human trophoblast-A review. Placenta 24, Supplement A, Trophoblast Research 17: 104-110
Pollheimer J, Bauer S, Huber A, Husslein P, Aplin JD, Knöfler M. (2004)
Expression pattern of collagen XVIII and its cleavage product, the angiogenesis inhibitor endostatin, at the fetal-maternal interface. Placenta 25:770-9
Pollheimer J, Husslein P, Knöfler M. (2005a)
Invasive trophoblasts generate regulatory collagen XVIII cleavage products. Placenta. 26: Suppl A:S42-5.
Pollheimer J, Husslein P, Knöfler M. (2005b)
Invasive trophoblasts generate regulatory collagen XVIII cleavage products. Placenta. 26: Suppl A:S42-5.
Pollheimer J, Loregger T, Sonderegger S, Saleh L, Bauer S, Bilban M, Czerwenka K, Husslein P, Knöfler M (2006)
Activation of the Canonical Wingless (Wnt) / T-cell factor (TCF) Signalling Pathway promotes Invasive Differentiation of Human Trophoblast. Am. J. Pathol., 168:1134-47.
Saleh L, Prast J, Haslinger P, Husslein P, Helmer H, Knöfler M. (2007)
Effects of Different Human Chorionic Gonadotrophin Preparations on Trophoblast Differentiation. Placenta 28:199-203
Sonderegger S, Husslein H, Leisser C, Knöfler M (2007)
Complex Expression Pattern of Wnt Ligands and Frizzled Receptors in Human Placenta and its Trophoblast Subtypes.
Placenta. 28 Suppl A:S97-S102.
Prast J, Saleh L, Husslein H, Sonderegger S, Helmer H, Knöfler M (2008)
Human chorionic gonadotrophin stimulates trophoblast invasion through ERK and AKT signalling. Endocrinology 149:979-87
Bilban M, Haslinger P, Prast J, Klinglmüller F, Woelfel T, Haider S, Sachs A, Otterbein LE, Desoye G, Hiden U, Wagner O, Knöfler M.
Identification of novel trophoblast invasion-related genes: Heme oxygenase-1 controls motility via PPAR{gamma} Endocrinology. 2008 Oct 9. [Epub ahead of print]